InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
5
已披露卖出
5
T+90 胜率
40%
T+90 平均收益
-5.6%
基于 5 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Pauls Matthew, Director. Officer active across 4 companies, notably Pelthos Therapeutics Inc.. In total, 22 filings have been published. Breakdown: 5 buys · 5 sells. Total volume traded: €443k. Activity tracked since 21 May 2021. The latest transaction was filed on 2 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Pauls Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
692 股@ US$25.99590.020% mcap87.5% 占其流量Common StockSEC:0001919246-26-000101:0
94 股@ US$27.36040.0029% mcap12.5% 占其流量Common StockSEC:0001919246-26-000101:1
415 股@ US$20.515422.9% 占其流量Common StockSEC:0001919246-26-000053:0
371 股@ US$21.362821.3% 占其流量Common StockSEC:0001919246-26-000053:1
25,478 股0Common StockSEC:0001919246-26-000042:0
195,705 股@ US$6.9290.4% 占其流量Common StockSEC:0001193125-25-321185:0
8,493 股0Common StockSEC:0001753926-25-001884:0
23,629 股0Common StockSEC:0001193125-25-316295:0
3,991 股0Common StockSEC:0001415889-25-016358:0
5,937 股@ US$4.60100.0% 占其流量Common StockSEC:0001415889-25-009298:0
400,000 股0Common StockSEC:0000950170-24-136782:0
6,500 股0Common StockSEC:0001415889-24-016310:0
84,000 股@ US$4.713139.0% 占其流量Common StockSEC:0001209191-23-060009:0
109,680 股@ US$4.4549.1% 占其流量Common StockSEC:0001209191-23-058850:0
325,000 股0Common StockSEC:0001209191-22-061411:0
62,318 股@ US$1.240.0055% mcap50.4% 占其流量Common StockSEC:0001209191-22-000131:0
400,000 股0Common StockSEC:0001209191-21-069586:0
6,500 股@ US$1.05990.0005% mcap4.5% 占其流量Common StockSEC:0001209191-21-068494:0
标准退出：2022年3月8日 (T+90)
10,000 股@ US$1.09540.0008% mcap7.1% 占其流量Common StockSEC:0001209191-21-067432:0
标准退出：2022年3月2日 (T+90)
10,000 股@ US$1.100.0008% mcap7.2% 占其流量Common StockSEC:0001209191-21-066036:0
标准退出：2022年2月16日 (T+90)
15,000 股@ US$1.181.2% 占其流量Common StockSEC:0001209191-21-052200:0
标准退出：2021年11月15日 (T+90)
10,000 股@ US$1.62981.0% 占其流量Common StockSEC:0001209191-21-035163:0
标准退出：2021年8月19日 (T+90)
22 条申报中的 22 条
About Pauls Matthew
Pauls Matthew is Director and appears in 22 filings in total. In the 22 recent filings sampled, the cumulative amounts are EUR 53,950 in buys and EUR 388,633 in sells, with filings dated from 2021-05-24 to 2026-07-07, and the main filings concern Savara Inc, Soleno Therapeutics INC and Pelthos Therapeutics Inc.
